Patients in Focus
We reached out to the following adult patients with moderate to severe RA, or moderate to severe UC who were prescribed XELJANZ after TNF blockers did not work well or could not be tolerated. Learn about their journeys on XELJANZ by exploring their stories below. Individual results may vary. Patient ambassador stories have been created in partnership with Pfizer.
Lisa loves going off the beaten path and taking in the local experiences when she travels. When she was diagnosed with moderate to severe RA, she wondered about the impact of her condition on activities she enjoys, like traveling. Lisa started taking methotrexate, but her symptoms of joint pain and swelling progressed. Then, Lisa tried a TNF blocker, but it didn't work well enough.
After reading an article about XELJANZ, Lisa decided to ask her doctor about it as a treatment option. After discussing the benefits and serious side effects with her doctor, Lisa started on XELJANZ. Her RA symptoms began to improve within several weeks.* She noticed less swelling in her hands and eventually helped her to feel less fatigue from her RA.
*In clinical trials, it took up to three months or longer for some patients to see improvement.
Individual results may vary.
At the time of her diagnosis, Lisa’s kids were in middle school and she was looking forward to high school graduations, proms, and traveling. For her, the most important thing was creating new memories with her family.
Lisa is focused on more than her RA symptoms. She enjoys yoga, spending quality time with her family, and creating new memories.
Take an active role in your treatment with tools and support resources—delivered directly to you. We’ll start by sending a Welcome Kit in the mail and will follow up with occasional emails containing timely information and lifestyle tips.
